191 related articles for article (PubMed ID: 28402723)
1. Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.
Pezzolo A; Sementa AR; Lerone M; Morini M; Ognibene M; Defferrari R; Mazzocco K; Conte M; Gigliotti AR; Garaventa A; Pistoia V; Varesio L
Cancer Biol Ther; 2017 May; 18(5):285-289. PubMed ID: 28402723
[TBL] [Abstract][Full Text] [Related]
2. Microarray based analysis of an inherited terminal 3p26.3 deletion, containing only the CHL1 gene, from a normal father to his two affected children.
Cuoco C; Ronchetto P; Gimelli S; Béna F; Divizia MT; Lerone M; Mirabelli-Badenier M; Mascaretti M; Gimelli G
Orphanet J Rare Dis; 2011 Apr; 6():12. PubMed ID: 21457564
[TBL] [Abstract][Full Text] [Related]
3. Neuronal migration genes and a familial translocation t (3;17): candidate genes implicated in the phenotype.
Hadj Amor M; Dimassi S; Taj A; Slimani W; Hannachi H; Mlika A; Ben Helel K; Saad A; Mougou-Zerelli S
BMC Med Genet; 2020 Feb; 21(1):26. PubMed ID: 32028920
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of a distal 3p deletion associated with fetoplacental chromosomal discrepancy and confined placental mosaicism detected by array comparative genomic hybridization.
Chen CP; Chen YY; Chern SR; Wu PS; Su JW; Chen WL; Wang W
Taiwan J Obstet Gynecol; 2013 Jun; 52(2):278-84. PubMed ID: 23915866
[TBL] [Abstract][Full Text] [Related]
5. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of a patient with 3p deletion syndrome and a review of the literature.
Fernandez TV; García-González IJ; Mason CE; Hernández-Zaragoza G; Ledezma-Rodríguez VC; Anguiano-Alvarez VM; E'Vega R; Gutiérrez-Angulo M; Maya ML; García-Bejarano HE; González-Cruz M; Barrios S; Atorga R; López-Cardona MG; Armendariz-Borunda J; State MW; Dávalos NO
Am J Med Genet A; 2008 Nov; 146A(21):2746-52. PubMed ID: 18837054
[TBL] [Abstract][Full Text] [Related]
7. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
8. FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions.
Dijkhuizen T; van Essen T; van der Vlies P; Verheij JB; Sikkema-Raddatz B; van der Veen AY; Gerssen-Schoorl KB; Buys CH; Kok K
Am J Med Genet A; 2006 Nov; 140(22):2482-7. PubMed ID: 17036314
[TBL] [Abstract][Full Text] [Related]
9. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
[TBL] [Abstract][Full Text] [Related]
10. Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.
Passariello A; De Brasi D; Defferrari R; Genesio R; Tufano M; Mazzocco K; Capasso M; Migliorati R; Martinsson T; Siani P; Nitsch L; Tonini GP
Eur J Med Genet; 2013 Nov; 56(11):626-34. PubMed ID: 24035971
[TBL] [Abstract][Full Text] [Related]
11. High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors.
Hoebeeck J; Michels E; Menten B; Van Roy N; Eggert A; Schramm A; De Preter K; Yigit N; De Smet E; De Paepe A; Laureys G; Vandesompele J; Speleman F
Int J Cancer; 2007 Feb; 120(3):533-8. PubMed ID: 17096344
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetic characterization of a subtle interstitial del(3)(p25.3p26.2) in a patient with deletion 3p syndrome.
Cargile CB; Goh DL; Goodman BK; Chen XN; Korenberg JR; Semenza GL; Thomas GH
Am J Med Genet; 2002 Apr; 109(2):133-8. PubMed ID: 11977162
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis and molecular cytogenetic characterization of de novo partial monosomy 3p (3p26.3→pter) and partial trisomy 16q (16q23.1→qter).
Chen CP; Hung FY; Chern SR; Wu PS; Chen YN; Chen SW; Lee CC; Wang W
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):288-92. PubMed ID: 27125417
[TBL] [Abstract][Full Text] [Related]
14. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
Fernandez T; Morgan T; Davis N; Klin A; Morris A; Farhi A; Lifton RP; State MW
Am J Hum Genet; 2004 Jun; 74(6):1286-93. PubMed ID: 15106122
[TBL] [Abstract][Full Text] [Related]
15. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
[TBL] [Abstract][Full Text] [Related]
16. Cell Adhesion Molecules Involved in Neurodevelopmental Pathways Implicated in 3p-Deletion Syndrome and Autism Spectrum Disorder.
Gandawijaya J; Bamford RA; Burbach JPH; Oguro-Ando A
Front Cell Neurosci; 2020; 14():611379. PubMed ID: 33519384
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
Manderson EN; Birch AH; Shen Z; Mes-Masson AM; Provencher D; Tonin PN
Int J Gynecol Cancer; 2009 May; 19(4):513-25. PubMed ID: 19509545
[TBL] [Abstract][Full Text] [Related]
18. Single gene microdeletions and microduplication of 3p26.3 in three unrelated families: CNTN6 as a new candidate gene for intellectual disability.
Kashevarova AA; Nazarenko LP; Schultz-Pedersen S; Skryabin NA; Salyukova OA; Chechetkina NN; Tolmacheva EN; Rudko AA; Magini P; Graziano C; Romeo G; Joss S; Tümer Z; Lebedev IN
Mol Cytogenet; 2014; 7(1):97. PubMed ID: 25606055
[TBL] [Abstract][Full Text] [Related]
19. A large Indian family with rearrangement of chromosome 4p16 and 3p26.3 and divergent clinical presentations.
Iype T; Alakbarzade V; Iype M; Singh R; Sreekantan-Nair A; Chioza BA; Mohapatra TM; Baple EL; Patton MA; Warner TT; Proukakis C; Kulkarni A; Crosby AH
BMC Med Genet; 2015 Nov; 16():104. PubMed ID: 26554554
[TBL] [Abstract][Full Text] [Related]
20.
Ognibene M; Pagnan G; Marimpietri D; Cangelosi D; Cilli M; Benedetti MC; Boldrini R; Garaventa A; Frassoni F; Eva A; Varesio L; Pistoia V; Pezzolo A
Oncotarget; 2018 May; 9(40):25903-25921. PubMed ID: 29899830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
